| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/13/2007 | WO2007101884A1 Novel use of antihistamine agents for the preventive or early treatment of inflammatory syndromes, in particular those triggered by togaviruses |
| 09/13/2007 | WO2007101873A2 Betulonic acid esters and betulinic acid polyalkylene-glycol derivatives for the treatment of viral infection and cancer |
| 09/13/2007 | WO2007101864A2 Compounds that modulate ppar activity, their preparation and use |
| 09/13/2007 | WO2007101863A1 Therapeutic combination of a 5ht2 receptor antagonist and of a 5ht2 receptor activator |
| 09/13/2007 | WO2007101850A1 Use of adenine-derived compounds for the treatment of lupus |
| 09/13/2007 | WO2007101832A1 An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms |
| 09/13/2007 | WO2007101802A1 4-amino-1,5-substituted 1,5-dihydro-imidazol-2-ones |
| 09/13/2007 | WO2007101782A1 Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them |
| 09/13/2007 | WO2007101710A1 Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases |
| 09/13/2007 | WO2007101641A1 Use of light-active indocyanine green for treating inflammatory disorders in the oral cavity |
| 09/13/2007 | WO2007101606A1 Thiosulfonate anti-inflammatory agents |
| 09/13/2007 | WO2007101573A1 Substituted arylsulfonamides as antiviral agents |
| 09/13/2007 | WO2007101560A1 Medicament formulations comprising fluoroquinolones |
| 09/13/2007 | WO2007101551A2 Phospholipid complexes of curcumin having improved bioavailability |
| 09/13/2007 | WO2007101531A1 Use of adenosine a1 and/or dual a1/a2b agonists for production of medicaments for treating diseases |
| 09/13/2007 | WO2007101400A1 Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process |
| 09/13/2007 | WO2007101371A1 Preparation and use of purine bis-amino acid esters |
| 09/13/2007 | WO2007101365A1 New flavane compound and its uses |
| 09/13/2007 | WO2007101357A2 Hair growth agent for the treatment of human keratin fibers, and method for the production thereof |
| 09/13/2007 | WO2007101353A1 A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation |
| 09/13/2007 | WO2007101349A1 Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis |
| 09/13/2007 | WO2007101347A1 Bir domain binding compounds |
| 09/13/2007 | WO2007087488A3 Indole sulfonamide modulators of progesterone receptors |
| 09/13/2007 | WO2007087419A3 Substituted 3-(5-membered unsaturated heterocyclyl) -1, 3-dihydro-indol-2-one derivatives as tyrosine kinase inhibitors for the treatment of cancer |
| 09/13/2007 | WO2007087367A9 Methods and compositions for modulating the mobilization of stem cells |
| 09/13/2007 | WO2007087283A3 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 09/13/2007 | WO2007087026A3 Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 09/13/2007 | WO2007085485A3 Lna modified phosphorothiolated oligonucleotides |
| 09/13/2007 | WO2007084949A3 Modulators of cardiac cell hypertrophy and hyperplasia |
| 09/13/2007 | WO2007084841A3 Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors |
| 09/13/2007 | WO2007084625A9 Novel compounds and methods for inhibiting p53 activity |
| 09/13/2007 | WO2007084247A9 Stable therapeutic formulations |
| 09/13/2007 | WO2007083146A3 The treatment of cognitive and psychotic disorders |
| 09/13/2007 | WO2007083060A3 Novel chalcone derivatives with antimitotic activity |
| 09/13/2007 | WO2007082808A3 Thiazoles as 11 beta-hsd1 inhibitors |
| 09/13/2007 | WO2007079840A3 Benzochromene derivatives |
| 09/13/2007 | WO2007079199A3 Substituted bis-amide metalloprotease inhibitors |
| 09/13/2007 | WO2007075876A3 Process for preparing a synthetic intermediate for preparation of branched nucleosides |
| 09/13/2007 | WO2007075307A3 Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate |
| 09/13/2007 | WO2007071915A3 Pharmaceutical product comprising porous silicon |
| 09/13/2007 | WO2007071850A3 Inhibition of the anti-fviii immune response |
| 09/13/2007 | WO2007071766A3 Phenoxy acetic acids as ppar delta activators |
| 09/13/2007 | WO2007071055A8 Compositions and methods for modulating gated ion channels |
| 09/13/2007 | WO2007070611A3 Nutritional supplement containing long-chain polyunsaturated fatty acids |
| 09/13/2007 | WO2007069068A3 Cell penetrating peptide conjugates for delivering nucleic acids into cells |
| 09/13/2007 | WO2007067981A3 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/13/2007 | WO2007065007A9 Treatment of viral infections |
| 09/13/2007 | WO2007063391A3 Spirocyclic quinazoline derivatives as pde7 inhibitors |
| 09/13/2007 | WO2007060170A3 Bilayer tablet comprising telmisartan and diuretic |
| 09/13/2007 | WO2007060140A3 Inhibitors of diacyglycerol acyltransferase (dgat) |
| 09/13/2007 | WO2007056457A3 Methods, compositions, and kits for the treatment of medical conditions |
| 09/13/2007 | WO2007056215A9 N-aryl-thienopyrimidin-4-amines and the use thereof |
| 09/13/2007 | WO2007051333A8 Triazine beta-secretase inhibitors |
| 09/13/2007 | WO2007049089A8 Method of stimulating growth of functional blood vessels and/or regeneration of myocardium in damaged tissues |
| 09/13/2007 | WO2007048002A3 Camptothecin derivatives as chemoradiosensitizing agents |
| 09/13/2007 | WO2007047951A3 Molecular delivery to cells using aspirin-related compounds |
| 09/13/2007 | WO2007047604A3 Sirt1 inhibition |
| 09/13/2007 | WO2007041524A3 Novel parenteral carbamazepine formulation |
| 09/13/2007 | WO2007041341A3 Identification of anti-cancer compounds and compounds for treating huntington's disease and methods of treatment thereof |
| 09/13/2007 | WO2007039178A3 Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 09/13/2007 | WO2007038758A3 Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition |
| 09/13/2007 | WO2007036945A3 Hepatocyte growth factor receptor splice variants and methods of using same |
| 09/13/2007 | WO2007035518A3 Aptamers as agonists |
| 09/13/2007 | WO2007031883A3 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof |
| 09/13/2007 | WO2007030780A3 Quinoline derivatives and use as antitumor agents |
| 09/13/2007 | WO2007030770A3 Endothelin receptors in morphine withdrawal |
| 09/13/2007 | WO2007030559A3 1, 3-disubstituted indole derivatives for use as ppar modulators |
| 09/13/2007 | WO2007027524A3 Halo active aromatic sulfonamide organic compounds and odor control uses therefor |
| 09/13/2007 | WO2007027238A3 Jak kinase inhibitors and their uses |
| 09/13/2007 | WO2007025303A3 Non-steroidal antiandrogens |
| 09/13/2007 | WO2007022138A3 Genistein inhibition of transthyretin amyloidosis |
| 09/13/2007 | WO2007019723A3 Food supplement agent based on rock |
| 09/13/2007 | WO2007015775A3 Potassium channel inhibitors |
| 09/13/2007 | WO2007010508A3 Controlled release compositions of metaxalone |
| 09/13/2007 | WO2006138418A3 Improvement of cognitive performance with sirtuin activators |
| 09/13/2007 | WO2006137840A3 Diphenyl ether antimicrobial compounds |
| 09/13/2007 | WO2006131651A3 Avermectin and hydrocortisone-based composition, in particular for roracea treatment |
| 09/13/2007 | WO2006130628A3 Combination of hcv protease inhibitors with a surfactant |
| 09/13/2007 | WO2006110473A3 Phospholipid-based pharmaceutical formulations and methods for producing and using same |
| 09/13/2007 | WO2006101922A3 Medicinal compositions of salts, chelates and/or free acids of alpha hydroxyl organic acids and related processes and methods |
| 09/13/2007 | WO2006099610A3 Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy |
| 09/13/2007 | WO2006084217A3 Rnai-mediated inhibition of ocular hypertension targets |
| 09/13/2007 | WO2006076216A3 Apoptosis-inducing antineoplastic silver (i) coordination complexes |
| 09/13/2007 | WO2006024627A3 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 09/13/2007 | WO2006002846A3 New analogs of nitrobenzylthioinosine |
| 09/13/2007 | WO2005102363A3 Methods of promoting cartilage healing or cartilage integration |
| 09/13/2007 | WO2005089764A9 Carboline derivatives useful in the inhibition of angiogenesis |
| 09/13/2007 | WO2005054224A3 Derivatives of dihydronepetalactone and method for preparation |
| 09/13/2007 | US20070213683 Systems, methods, and compositions for prevention of tissue adhesion |
| 09/13/2007 | US20070213543 Prevention of ovarian cancer by administration of agents that induce biologic responses |
| 09/13/2007 | US20070213408 Use of Acetyl L-Carnitine for the Preparation of a Medicine for the Treatment of Neuropathic Pain in Diabetic Patients |
| 09/13/2007 | US20070213407 Compounds to treat Alzheimer's disease |
| 09/13/2007 | US20070213406 Anti-Inflammatory Analgesic External Aqueus Liquid Preparation |
| 09/13/2007 | US20070213405 Crystalline forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride |
| 09/13/2007 | US20070213404 Processes for preparation of polymorphic form II of sertraline hydrochloride |
| 09/13/2007 | US20070213403 Tamoxifen response in pre-and postmenopausal breast cancer patients |
| 09/13/2007 | US20070213402 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 09/13/2007 | US20070213401 Pharmaceutical uses for alpha2delta ligands |
| 09/13/2007 | US20070213400 Alcohol-metabolism enhancing composition and ingesta containing the same |
| 09/13/2007 | US20070213399 Modulation of nitric oxide synthases by betaines |